Persistent β2*-Nicotinic Acetylcholinergic Receptor Dysfunction in Major Depressive Disorder
Aybala Saricicek, M.D.; Irina Esterlis, Ph.D.; Kathleen H. Maloney, B.A.; Yann S. Mineur, Ph.D.; Barbara M. Ruf, B.A.; Anjana Muralidharan, B.A.; Jason I. Chen, B.A.; Kelly P. Cosgrove, Ph.D.; Rebecca Kerestes, Ph.D.; Subroto Ghose, M.D., Ph.D.; Carol A. Tamminga, M.D.; Brian Pittman, M.S.; Frederic Bois, Ph.D.; Gilles Tamagnan, Ph.D.; John Seibyl, M.D.; Marina R. Picciotto, Ph.D.; Julie K. Staley, Ph.D.; Zubin Bhagwagar, M.D., Ph.D., M.R.C.Psych.
From the Department of Psychiatry, Yale University, New Haven, Conn.; the Neuroscience Group, Bristol-Myers Squibb, Wallingford, Conn.; the Institute for Neurodegenerative Disorders, New Haven, Conn.; and the Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas.
Am J Psychiatry 2012;169:851-859.
doi:10.1176/appi.ajp.2012.11101546
Purchase Online access to this article for 24 hours
Clicking on the buy now link will redirect you to the shopping cart at APPI.org where you will be asked to log in or create an account to complete your transaction. Once your transaction is complete, you will receive an email with instructions for accessing this content online and in PDF format.
You may view, download, and/or print the article for your personal, scholarly, research, and educational use. You may not (i) distribute a copy
(electronic or otherwise) of the article without the written permission of APA, (ii) post the article on an electronic bulletin board or web
site, or (iii) charge for a copy (electronic or otherwise) of the article.